Table 5 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
收藏数据链接：
官方服务：
资源简介：
Incidence of related AEs and SAEs observed during WBHT administered as monotherapy or in combination with chemotherapy.
创建时间：
2026-02-04
